Histamine promotes the development of monocyte-derived dendritic cells and reduces tumor growth by targeting the myeloid NADPH oxidase

Journal of Immunology

Volumn 194, Issue 10, 2015, Pages 5014-5021

  Martner, Anna ^a   Wiktorin, Hanna G ^a   Lenox, Brianna ^a   Sander, Frida Ewald ^a   Aydin, Ebru ^a   Aurelius, Johan ^a   Thorén, Fredrik B ^a   Ståhlberg, Anders ^a   Hermodsson, Svante ^a   Hellstrand, Kristoffer ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; HLA DR ANTIGEN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CELL ISOLATION; CELL MATURATION; CHEMOLUMINESCENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOMA; MONOCYTE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TUMOR GROWTH; WILD TYPE; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; FLOW CYTOMETRY; HISTAMINE; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MONOCYTES; NADPH OXIDASE; NEOPLASMS, EXPERIMENTAL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 84929094844     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402991     Document Type: Article

References (37)

1. Gabrilovich, D. 2004. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 4: 941-952.
2. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
3. Gabrilovich, D. I., S. Ostrand-Rosenberg, and V. Bronte. 2012. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12: 253-268.
4. Lee, B. N., M. Follen, G. Rodriquez, D. Y. Shen, A. Malpica, W. T. Shearer, and J. M. Reuben. 2006. Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions. Cancer 107: 999-1007.
5. Pinzon-Charry, A., C. S. Ho, T. Maxwell, M. A. McGuckin, C. Schmidt, C. Furnival, C. M. Pyke, and J. A. López. 2007. Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer. Br. J. Cancer 97: 1251-1259.
6. Pinzon-Charry, A., T. Maxwell, and J. A. López. 2005. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol. Cell Biol. 83: 451-461.
7. Yang, X. D., W. Ai, S. Asfaha, G. Bhagat, R. A. Friedman, G. Jin, H. Park, B. Shykind, T. G. Diacovo, A. Falus, and T. C. Wang. 2011. Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat. Med. 17: 87-95.
8. Hellstrand, K., A. Asea, C. Dahlgren, and S. Hermodsson. 1994. Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites. J. Immunol. 153: 4940-4947.
9. Brune, M., M. Hansson, U. H. Mellqvist, S. Hermodsson, and K. Hellstrand. 1996. NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites. Eur. J. Haematol. 57: 312-319.
10. Aurelius, J., A. Martner, M. Brune, L. Palmqvist, M. Hansson, K. Hellstrand, and F. B. Thoren. 2012. Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells. Haematologica 97: 1904-1908.
11. Mellqvist, U. H., M. Hansson, M. Brune, C. Dahlgren, S. Hermodsson, and K. Hellstrand. 2000. Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine. Blood 96: 1961-1968.
12. Rada, B., and T. L. Leto. 2008. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib. Microbiol. 15: 164-187.
13. Hellstrand, K., M. Hansson, and S. Hermodsson. 2000. Adjuvant histamine in cancer immunotherapy. Semin. Cancer Biol. 10: 29-39.
14. Brune, M., S. Castaigne, J. Catalano, K. Gehlsen, A. D. Ho, W. K. Hofmann, D. E. Hogge, B. Nilsson, R. Or, A. I. Romero, et al. 2006. Improved leukemiafree survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial. Blood 108: 88-96.
15. Martner, A., F. B. Thorén, J. Aurelius, and K. Hellstrand. 2013. Immunotherapeutic strategies for relapse control in acute myeloid leukemia. Blood Rev. 27: 209-216.
16. Kusmartsev, S., and D. I. Gabrilovich. 2003. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. J. Leukoc. Biol. 74: 186-196.
17. Tucker, K. A., M. B. Lilly, L. Heck, Jr., and T. A. Rado. 1987. Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity. Blood 70: 372-378.
18. Zhen, L., A. A. King, Y. Xiao, S. J. Chanock, S. H. Orkin, and M. C. Dinauer. 1993. Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox. Proc. Natl. Acad. Sci. USA 90: 9832-9836.
19. Svec, D., D. Andersson, M. Pekny, R. Sjoback, M. Kubista, and A. Stahlberg. 2013. Direct cell lysis for single-cell gene expression profiling. Front. Oncol. 3: 274. Available at: http://journal.frontiersin.org/article/10.3389/fonc.2013.00274/full.
20. Ståhlberg, A., K. Elbing, J. M. Andrade-Garda, B. Sjögreen, A. Forootan, and M. Kubista. 2008. Multiway real-time PCR gene expression profiling in yeast Saccharomyces cerevisiae reveals altered transcriptional response of ADH-genes to glucose stimuli. BMC Genomics 9: 170. Available at: http://www.biomedcentral.com/1471-2164/9/170.
21. Dahlgren, C., and A. Karlsson. 1999. Respiratory burst in human neutrophils. J. Immunol. Meth. 232: 3-14.
22. Vasicek, O., A. Lojek, V. Jancinova, R. Nosal, and M. Ciz. 2014. Role of histamine receptors in the effects of histamine on the production of reactive oxygen species by whole blood phagocytes. Life Sci. 100: 67-72.
23. Cairns, R. A., I. S. Harris, and T. W. Mak. 2011. Regulation of cancer cell metabolism. Nat. Rev. Cancer 11: 85-95.
24. Herber, D. L., W. Cao, Y. Nefedova, S. V. Novitskiy, S. Nagaraj, V. A. Tyurin, A. Corzo, H. I. Cho, E. Celis, B. Lennox, et al. 2010. Lipid accumulation and dendritic cell dysfunction in cancer. Nat. Med. 16: 880-886.
25. Nagaraj, S., V. Pisarev, L. Kinarsky, S. Sherman, C. Muro-Cacho, D. C. Altieri, and D. I. Gabrilovich. 2007. Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors. J. Immunother. 30: 169-179.
26. Esche, C., V. M. Subbotin, C. Maliszewski, M. T. Lotze, and M. R. Shurin. 1998. FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma. Cancer Res. 58: 380-383.
27. Satpathy, A. T., X. Wu, J. C. Albring, and K. M. Murphy. 2012. Re(de)fining the dendritic cell lineage. Nat. Immunol. 13: 1145-1154.
28. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
29. Frei, R., R. Ferstl, P. Konieczna, M. Ziegler, T. Simon, T. M. Rugeles, S. Mailand, T. Watanabe, R. Lauener, C. A. Akdis, and L. O'Mahony. 2013. Histamine receptor 2 modifies dendritic cell responses to microbial ligands. J. Allergy Clin. Immunol. 132: 194-204.
30. Caron, G., Y. Delneste, E. Roelandts, C. Duez, J. Y. Bonnefoy, J. Pestel, and P. Jeannin. 2001. Histamine polarizes human dendritic cells into Th2 cellpromoting effector dendritic cells. J. Immunol. 167: 3682-3686.
31. Gutzmer, R., K. Langer, M. Lisewski, S. Mommert, D. Rieckborn, A. Kapp, and T. Werfel. 2002. Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. J. Allergy Clin. Immunol. 109: 524-531.
32. Mazzoni, A., H. A. Young, J. H. Spitzer, A. Visintin, and D. M. Segal. 2001. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J. Clin. Invest. 108: 1865-1873.
33. Zhai, R. R., A. P. Jiang, H. B. Wang, L. Ma, X. X. Ren, J. F. Jiang, L. Wu, J. F. Wei, and J. H. Wang. 2013. Histamine enhances HIV-1-induced modulation of dendritic cells to skew naïve T cell differentiation toward regulatory T cells. Virology 442: 163-172.
34. Teuscher, C., M. E. Poynter, H. Offner, A. Zamora, T. Watanabe, P. D. Fillmore, J. F. Zachary, and E. P. Blankenhorn. 2004. Attenuation of Th1 effector cell responses and susceptibility to experimental allergic encephalomyelitis in histamine H2 receptor knockout mice is due to dysregulation of cytokine production by antigen-presenting cells. Am. J. Pathol. 164: 883-892.
35. Saligrama, N., L. K. Case, R. del Rio, R. Noubade, and C. Teuscher. 2013. Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis. J. Immunol. 191: 614-622.
36. Saligrama, N., R. Noubade, L. K. Case, R. del Rio, and C. Teuscher. 2012. Combinatorial roles for histamine H1-H2 and H3-H4 receptors in autoimmune inflammatory disease of the central nervous system. Eur. J. Immunol. 42: 1536-1546.
37. Asemissen, A. M., C. Scheibenbogen, A. Letsch, K. Hellstrand, F. Thoren, K. Gehlsen, A. Schmittel, E. Thiel, and U. Keilholz. 2005. Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104). Clin. Cancer Res. 11: 290-297.